Orbimed Advisors increased stake in X4 Pharmaceuticals, Inc. By Investing.com
© Reuters. Orbimed Advisors increased stake in X4 Pharmaceuticals, Inc. On the 23rd of March, Orbimed Advisors bought 750 thousand X4 Pharmaceuticals, Inc. (NASDAQ:) shares for $7 million at an average price of $9.31 per […]
